The hard part of the Iress story used to be figuring out what kind of company it was becoming.
That question is easier now. Iress Limited (ASX:IRE) has sold non-core assets, refocused around Wealth and Trading & Market Data software, restored its balance sheet and brought dividends back into the conversation. The next question is less dramatic, but more important: can the cleaner business now grow without leaning too heavily on cost cuts?
The FY25 result gave investors a first look at that version of Iress. Adjusted EBITDA came in at A$136.2 million, ahead of guidance, while underlying profit after tax rose 16.6% to A$73.9 million. Statutory NPAT was A$79.3 million, down 10.6% on FY24, which is a useful reminder that the headline story still carries noise from the restructuring period.
The Business Is Easier to Read Now
Iress has spent the past two years becoming smaller on purpose.
The company says it has completed its simplification into a focused Wealth and Trading & Market Data software business. That matters because the old Iress story had too many moving parts: multiple product lines, different geographies, asset sales, takeover interest and questions about capital allocation. The cleaner version is easier for the market to judge, but also easier to mark down if execution slips.
Continuing Business revenue rose 6.5% to A$504.3 million in FY25. Continuing Business Adjusted EBITDA increased 14.9% to A$132.6 million, with margin expansion across the continuing base. Headline revenue fell 7.1% to A$561.7 million because divested businesses no longer contributed, so the real read is not the group revenue line. It is the continuing business underneath it.
That is the key shift. Iress is no longer asking investors to look through complexity forever. It is asking them to judge a more focused software company on revenue growth, margins, product delivery and cash generation.
The Margin Target Is the New Scoreboard
The most important number in the FY26 setup may not be revenue guidance. It may be the margin target.
Iress expects FY26 revenue of A$520 million to A$528 million, Cash EBITDA of A$116 million to A$123 million and UPAT of A$84 million to A$90 million. It is also targeting a FY26 Cash EBITDA margin exit run-rate above 25%.
That puts a clear test in front of management.
The company’s business efficiency program is targeting about A$30 million in annualised cost reductions by the end of FY26, with around 60% already achieved at the time of the FY25 result. The market can understand that story. Cut stranded costs, reinvest into core platforms, sharpen pricing and make the product set easier to sell.
The catch is that cost programs have a shelf life. They can lift margins quickly, but they do not settle the longer-term question on their own. For Iress, the more durable test is whether clients keep paying more, adopting more modules and staying on the platform as the technology stack is modernised.
Why the Clean Story Still Has Friction
There is a constructive reading of the result. Iress has reduced leverage, improved continuing earnings, paid a final dividend of 13.0 cents per share, 100% franked, and given investors a cleaner FY26 framework. The balance sheet is also in a better position, with leverage at 0.5 times at 31 December 2025, down from 1.0 times a year earlier.
There is also a more cautious reading.
A cleaner business is not automatically a faster-growing business. Iress still needs to show that its core Wealth and Trading & Market Data units can compound beyond price increases and efficiency gains. The company is investing in platform modernisation and AI-enabled capabilities, but investors will want evidence that those investments improve retention, client wins or product usage, not just the slide deck.
The other tension is corporate activity. Iress said it had engaged with third parties over the past year, but no change-of-control offer had been received. The board said the preferred path is disciplined execution in public markets, while still leaving the door open to any bona fide proposal that recognises the company’s value.
That leaves Iress in a cleaner, but more exposed, position. The asset-sale chapter helped reset the company. FY26 has to show whether the operating business can carry the story from here.
The Next Result Has to Show Quality, Not Just Progress
The next set of numbers should tell investors more than the FY25 headline did.
Watch continuing revenue growth, Cash EBITDA margin, capitalised software spend, client wins and any commentary on pricing. Also watch whether the efficiency program keeps flowing through without starving product investment. A software company can cut its way to better near-term margins, but it has to build its way into a better multiple.
For now, Iress has given investors a simpler story. That is progress. It also removes some of the hiding places.
